Literature DB >> 14691214

DNA adduct formation in precision-cut rat liver and lung slices exposed to benzo[a]pyrene.

Jeanine A Harrigan1, Chad M Vezina, Barbara P McGarrigle, Noreen Ersing, Harold C Box, Alexander E Maccubbin, James R Olson.   

Abstract

Chemical-DNA adducts provide an integrated measure of exposure, absorption, bioactivation, detoxification, and DNA repair following exposure to a genotoxic agent. Benzo[a]pyrene (BaP), a prototypical polycyclic aromatic hydrocarbon (PAH), can be bioactivated by cytochrome P-450s (CYPs) and epoxide hydrolase to genotoxic metabolites which form covalent adducts with DNA. In this study, we utilized precision-cut rat liver and lung slices exposed to BaP to investigate tissue-specific differences in chemical absorption and formation of DNA adducts. To investigate the contribution of bioactivating CYPs (such as CYP1A1 and CYP1B1) on the formation of BaP-DNA adducts, animals were also pretreated in vivo with 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD, dioxin) prior to in vitro incubation of tissue slices with BaP. Furthermore, the tissue distribution of BaP and BaP-DNA adduct levels from in vivo studies were compared with those from the in vitro tissue slice experiments. The results indicate a time- and concentration-dependent increase in tissue-associated BaP following exposure of rat liver and lung tissue slices to BaP in vitro, with generally higher levels of BaP retained in lung tissue. Furthermore, rat liver and lung slices metabolized BaP to reactive intermediates that formed covalent adducts with DNA. Total BaP-DNA adducts increased with concentration and incubation time. Adduct levels (fmol adduct/microg DNA) in lung slices were greater than liver at all doses. Liver slices contained one major and two minor adducts, while lung slices contained two major and 3 minor adducts. The tissue-specific qualitative profile of these adducts in tissue slices was similar to that observed from in vivo studies, further validating the use of this model. Pretreatment of animals with TCDD prior to in vitro incubation with BaP potentiated the levels of DNA adduct formation. TCDD pretreatment altered the adduct distribution in lung but not in liver slices. Together, the results suggest that tissue-specific qualitative and quantitative differences in BaP-DNA adducts could contribute to the lung being a target tissue for BaP carcinogenesis. Furthermore, the results validate the use of precision-cut tissue slices incubated in dynamic organ culture as a useful model for the study of chemical-DNA adduct formation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14691214     DOI: 10.1093/toxsci/kfh030

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  21 in total

Review 1.  How cigarette smoke skews immune responses to promote infection, lung disease and cancer.

Authors:  Martin R Stämpfli; Gary P Anderson
Journal:  Nat Rev Immunol       Date:  2009-05       Impact factor: 53.106

2.  Characterization of the recalcitrant CYP1 phenotype found in Atlantic killifish (Fundulus heteroclitus) inhabiting a Superfund site on the Elizabeth River, VA.

Authors:  Lauren P Wills; Cole W Matson; Chelsea D Landon; Richard T Di Giulio
Journal:  Aquat Toxicol       Date:  2010-04-14       Impact factor: 4.964

3.  Organotypic Models of Lung Cancer.

Authors:  Anna Pomerenke
Journal:  Curr Top Microbiol Immunol       Date:  2021       Impact factor: 4.291

4.  Human T lymphocytes bioactivate heterocyclic aromatic amines by forming DNA adducts.

Authors:  Medjda Bellamri; Ludovic Le Hegarat; Laurent Vernhet; Georges Baffet; Robert J Turesky; Sophie Langouët
Journal:  Environ Mol Mutagen       Date:  2016-11-01       Impact factor: 3.216

5.  Cytokine and chemokine responses of lung exposed to surrogate viral and bacterial infections.

Authors:  Teresa A Liberati; Rita A Trammell; Michelle Randle; Sarah Barrett; Linda A Toth
Journal:  Comp Med       Date:  2013-04       Impact factor: 0.982

6.  UVR exposure sensitizes keratinocytes to DNA adduct formation.

Authors:  Sudhir Nair; Vikram D Kekatpure; Benjamin L Judson; Arleen B Rifkind; Richard D Granstein; Jay O Boyle; Kotha Subbaramaiah; Joseph B Guttenplan; Andrew J Dannenberg
Journal:  Cancer Prev Res (Phila)       Date:  2009-09-29

7.  Effect of CYP1A inhibition on the biotransformation of benzo[a]pyrene in two populations of Fundulus heteroclitus with different exposure histories.

Authors:  Lauren P Wills; Shiqian Zhu; Kristine L Willett; Richard T Di Giulio
Journal:  Aquat Toxicol       Date:  2009-01-31       Impact factor: 4.964

8.  HDAC6 modulates Hsp90 chaperone activity and regulates activation of aryl hydrocarbon receptor signaling.

Authors:  Vikram D Kekatpure; Andrew J Dannenberg; Kotha Subbaramaiah
Journal:  J Biol Chem       Date:  2009-01-21       Impact factor: 5.157

9.  Simultaneous determination of benzo[a]pyrene and eight of its metabolites in Fundulus heteroclitus bile using ultra-performance liquid chromatography with mass spectrometry.

Authors:  Shiqian Zhu; Lie Li; Cammi Thornton; Paulo Carvalho; Bonnie A Avery; Kristine L Willett
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2008-01-18       Impact factor: 3.205

10.  Carnosol, a constituent of Zyflamend, inhibits aryl hydrocarbon receptor-mediated activation of CYP1A1 and CYP1B1 transcription and mutagenesis.

Authors:  Arash Mohebati; Joseph B Guttenplan; Amit Kochhar; Zhong-Lin Zhao; Wieslawa Kosinska; Kotha Subbaramaiah; Andrew J Dannenberg
Journal:  Cancer Prev Res (Phila)       Date:  2012-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.